Clin2
NCT06526221Likely a fitEnrolling by invitation

Urine test to check TB medication use

Tuberculosis, PulmonaryMedication Adherence

Part of Infections, Lungs & breathing clinical trials.

This study checks a simple urine test to see if people with TB are taking their medication (isoniazid) regularly. It aims to help doctors find out sooner if someone is missing doses, so they can offer extra support.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
900 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years old or older.
  • You have or are suspected to have drug-sensitive TB in your lungs (this includes people who have had TB before).
  • You are currently taking a TB treatment that includes a medicine called isoniazid.
  • You are able to understand and agree to take part in the study.
  • You do not have drug-resistant TB and you have not switched to a TB treatment without isoniazid.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06845618Recruiting
Blood test to monitor tuberculosis treatment

This study is looking at how a simple blood test can help monitor tuberculosis (TB) treatment. It may help doctors know sooner if the treatment is working.

Tak
NCT07708779Recruiting· Phase 1
Inhaled isoniazid for tuberculosis treatment

This trial tests inhaled isoniazid (medicine) given through a nebulizer to see how well it works and how safe it is. It's for people being treated for tuberculosis.

Groningen
NCT07472348Not yet recruiting
Isoniazid and liver safety in tuberculosis treatment

This study looks at how often isoniazid, a medicine used to treat tuberculosis, causes liver damage in everyday practice, and what factors might predict that risk. If you are taking or have taken isoniazid, this research may help doctors understand your risk and improve safety for other patients.

Milan, Italy
NCT07595042Not yet recruiting· Phase 2
Personalized TB treatment study

This study tests different treatment plans for people with tuberculosis (TB) that can be cured with standard medicines. It aims to find the best treatment for each person based on their risk score, which may lead to shorter or more effective treatment.

Buenos Aires
NCT06318416Recruiting· Phase 1
Precision Rifampin Dosing for TB

This study tests whether giving a personalized dose of rifampin (a key TB medicine) can improve treatment. It is for people with active TB that is sensitive to rifampin, and it involves frequent blood and urine tests to measure drug levels.

Haydom
NCT06764576Recruiting
Study for people with suspected tuberculosis or related infections

This trial is looking for adults who might have tuberculosis, a related infection called non-tubercular mycobacteriosis, or a hidden (latent) tuberculosis infection. You will provide a sample for testing, and the study will help doctors understand and manage these infections better.

Bologna

Hear when a new Tuberculosis, Pulmonary trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.